Summary
Cardiovascular diseases (CVDs) affect people of all ages, genders and backgrounds and are a leading cause of death worldwide. The care pathways for CVD patients are highly intricate, involving numerous diagnostic procedures and treatment approaches. Today, there are critical gaps in the early detection, diagnosis and treatment of CVDs. Innovative technologies are being developed, but managing their smooth integration into care pathways is far from easy.
The aim of the GRACE project is to create a framework to improve the care pathways of people with CVD, from diagnosis to treatment and long-term management. At the healthcare system level, the framework will facilitate the seamless integration of new technologies into care pathways. At the individual level, the framework will provide tools for patients and healthcare workers to improve diagnosis and care.
At the heart of the project are six use cases covering four common CVDs (arrhythmias, structural heart disease, coronary artery disease and heart failure) and targeting the general population, the elderly, and patients with other diseases.
Each use case will explore how best to integrate into care pathways technological approaches to diagnosing and managing CVDs that are provided by the industrial and SME partners in the project. Here the team will focus on the entire continuum of care, seeking to ensure a smooth, efficient and cost-effective collaboration between different disciplines and clinical settings. They will also take into account the views of a wide range of stakeholders, including patients and their caregivers.
The result of these efforts will feed into assessment tools, policy recommendations and best practices to help healthcare services review new technologies and integrate them into their work. Patients will benefit from artificial intelligence tools to aid in early diagnosis, as well as apps for personalised monitoring and treatment/care recommendations.
Ultimately, GRACE will benefit patients by guiding them to a faster, more reliable diagnosis and smoother, more personalised care pathways as they undergo treatment and follow-up. For healthcare systems, GRACE offers the promise of greater efficiency by facilitating the integration of new technologies and improving the flow of information between different groups involved in the care of people with CVDs.
Participants
Show participants on mapUniversities, research organisations, public bodies, non-profit groups
- Centre Hospitalier Universitaire De Rennes, Rennes Cedex 9, France
- Centro Nacional De Investigaciones Cardiovasculares Carlos Iii (F.S.P.), Madrid, Spain
- Ethniko Kentro Erevnas Kai Technologikis Anaptyxis, Thermi Thessaloniki, Greece
- Fondazione Policlinico Universitario Agostino Gemelli Irccs, Roma, Italy
- Fondazione Policlinico Universitario Campus Bio Medico, Roma, Italy
- Fundacion Para La Investigacion Biosanitaria De Andalucia Oriental-Alejandro Otero, Granada, Spain
- Institut Catala De La Salut, Barcelona, Spain
- Servicio Madrileno De Salud, Madrid, Spain
- Udg Alliance, Lausanne, Switzerland
- Universita Campus Bio Medico Di Roma, Roma, Italy
- Universitair Medisch Centrum Utrecht, Utrecht, Netherlands
- Universitatsklinikum Bonn, Bonn, Germany
Small and medium-sized enterprises (SMEs) and mid-sized companies (<€500 m turnover)
- Active Ageing Association, Paterna, Spain
- Bridg Ou, Tallin, Estonia
- Happy Mondays Communication SL, Pozuelo De Alarcon, Spain
- Human Factor & Innovation SRL Start-Up, Milano, Italy
- Outcomes'10 SL, Castellon de la Plana, Spain
- Predictby Research And Consulting S.L., Barcelona, Spain
- Wavy Assistant B.V., Groningen, Netherlands
IHI industry partners
- Astrazeneca Farmaceutica Spain, S.A, Madrid, Spain
- Dedalus Italia S.P.A., Firenze, Italy
- Medtronic France, Boulogne, France
- Medtronic Iberica SA, Madrid, Spain
- Philips Medical Systems Nederland BV, Best, Netherlands
- Philips Medical Systems Technologies LTD, Haifa, Israel
- Samsung Electronics (Uk) Limited, Chertsey - Surrey, United Kingdom
- Samsung Electronics, Suwon, Korea (Republic of)
Participants | |
---|---|
Name | EU funding in € |
Active Ageing Association | 350 000 |
Bridg Ou | 335 000 |
Centre Hospitalier Universitaire De Rennes | 426 188 |
Centro Nacional De Investigaciones Cardiovasculares Carlos Iii (F.S.P.) | 405 625 |
Dedalus Italia S.P.A. | 957 395 |
Ethniko Kentro Erevnas Kai Technologikis Anaptyxis | 102 228 |
Fondazione Policlinico Universitario Agostino Gemelli Irccs | 304 000 |
Fondazione Policlinico Universitario Campus Bio Medico | 100 250 |
Fundacion Para La Investigacion Biosanitaria De Andalucia Oriental-Alejandro Otero | 348 750 |
Happy Mondays Communication SL | 335 000 |
Human Factor & Innovation SRL Start-Up | 70 000 |
Institut Catala De La Salut | 340 460 |
Medtronic France | 435 533 |
Medtronic Iberica SA | 1 610 500 |
Outcomes'10 SL | 106 625 |
Philips Medical Systems Nederland BV | 1 696 400 |
Philips Medical Systems Technologies LTD | 640 000 |
Predictby Research And Consulting S.L. | 254 500 |
Samsung Electronics (Uk) Limited | 1 179 250 |
Servicio Madrileno De Salud | 401 500 |
Universita Campus Bio Medico Di Roma | 435 250 |
Universitair Medisch Centrum Utrecht | 392 475 |
Universitatsklinikum Bonn | 314 375 |
Wavy Assistant B.V. | 195 000 |
Total Cost | 11 736 304 |